Skip to main content
Premium Trial:

Request an Annual Quote

William Sharp, Steven Stice

Premium
Aruna Biomedical announced this week that William Sharp has been named president and chief executive officer. Sharp has also been appointed to Aruna's board of directors. He succeeds Aruna founder Steven Stice,who will remain Aruna's chairman and chief scientific officer. 
 

Sharp most recently served as chief commercial officer of BioProcessors, a venture-financed life science tools developer based near Boston, Mass. Prior to BioProcessors, he was senior vice president of business development at Cellomics, vice president of business development at Gentra Systems, worldwide director for the molecular biology business of Life Technologies (now Invitrogen), and vice president of sales and marketing at Heraeus Instruments

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more